Trust Investment Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,972
Closed -$1.21M 130
2024
Q1
$1.21M Sell
24,972
-726
-3% -$35.5K 0.88% 46
2023
Q4
$1.28M Sell
25,698
-1,502
-6% -$73.4K 1% 39
2023
Q3
$1.46M Sell
27,200
-212
-0.8% -$11.3K 1.25% 24
2023
Q2
$1.48M Sell
27,412
-3,089
-10% -$166K 1.19% 28
2023
Q1
$1.66M Buy
30,501
+10,681
+54% +$520K 1.49% 14
2022
Q4
$960K Sell
19,820
-7,606
-28% -$334K 0.91% 48
2022
Q3
$1.04M Sell
27,426
-339
-1% -$15.1K 1.09% 39
2022
Q2
$1.39M Sell
27,765
-140
-0.5% -$7.43K 1.33% 20
2022
Q1
$1.43M Buy
+27,905
New +$1.44M 1.17% 31

Other funds holding SNY

Trust Investment Advisors's SNY Position: Q2 2024 in Review

Trust Investment Advisors sold out of Sanofi (SNY) in Q2 2024, closing a stake of 24,972 shares — an estimated $1.21M sold.

Trust Investment Advisors first reported a position in SNY in Q1 2022 and held it in 9 quarters. The position peaked at $1.66M in Q1 2023. 728 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

  • Trust Investment Advisors reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
  • Trust Investment Advisors sold 24,972 Sanofi shares in Q2 2024, an estimated $1.21M.
  • Trust Investment Advisors first reported a position in Sanofi in Q1 2022 and held it in 9 quarters.
  • Trust Investment Advisors's Sanofi position peaked at $1.66M in Q1 2023.
  • 728 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on Trust Investment Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.